216 related articles for article (PubMed ID: 38339931)
1. Vitamin D Reduces GABA-Positive Astrocytes in the 5xFAD Mouse Model of Alzheimer's Disease.
Kang J; Park M; Kim T
J Alzheimers Dis; 2024; 97(4):1939-1950. PubMed ID: 38339931
[TBL] [Abstract][Full Text] [Related]
2. Astrocyte Reactivity in Alzheimer's Disease: Therapeutic Opportunities to Promote Repair.
Mirzaei N; Davis N; Chau TW; Sastre M
Curr Alzheimer Res; 2022; 19(1):1-15. PubMed ID: 34719372
[TBL] [Abstract][Full Text] [Related]
3. The neuroprotective N-terminal amyloid-β core hexapeptide reverses reactive gliosis and gliotoxicity in Alzheimer's disease pathology models.
Lantz MJ; Roberts AM; Delgado DD; Nichols RA
J Neuroinflammation; 2023 May; 20(1):129. PubMed ID: 37245024
[TBL] [Abstract][Full Text] [Related]
4. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
[TBL] [Abstract][Full Text] [Related]
5. A Role of Low-Density Lipoprotein Receptor-Related Protein 4 (LRP4) in Astrocytic Aβ Clearance.
Zhang H; Chen W; Tan Z; Zhang L; Dong Z; Cui W; Zhao K; Wang H; Jing H; Cao R; Kim C; Safar JG; Xiong WC; Mei L
J Neurosci; 2020 Jul; 40(28):5347-5361. PubMed ID: 32457076
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of Alzheimer's Disease Amyloid-β Protein Precursor in Astrocytes Both in vitro and in vivo.
Liang Y; Raven F; Ward JF; Zhen S; Zhang S; Sun H; Miller SJ; Choi SH; Tanzi RE; Zhang C
J Alzheimers Dis; 2020; 76(3):1071-1082. PubMed ID: 32597805
[TBL] [Abstract][Full Text] [Related]
7. Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer's Disease.
Olsen M; Aguilar X; Sehlin D; Fang XT; Antoni G; Erlandsson A; Syvänen S
Mol Imaging Biol; 2018 Aug; 20(4):605-614. PubMed ID: 29297157
[TBL] [Abstract][Full Text] [Related]
8. Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis.
Mahan TE; Wang C; Bao X; Choudhury A; Ulrich JD; Holtzman DM
Mol Neurodegener; 2022 Feb; 17(1):13. PubMed ID: 35109920
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological ablation of astrocytes reduces Aβ degradation and synaptic connectivity in an ex vivo model of Alzheimer's disease.
Davis N; Mota BC; Stead L; Palmer EOC; Lombardero L; Rodríguez-Puertas R; de Paola V; Barnes SJ; Sastre M
J Neuroinflammation; 2021 Mar; 18(1):73. PubMed ID: 33731156
[TBL] [Abstract][Full Text] [Related]
10. Astrocyte remodeling in the beneficial effects of long-term voluntary exercise in Alzheimer's disease.
Belaya I; Ivanova M; Sorvari A; Ilicic M; Loppi S; Koivisto H; Varricchio A; Tikkanen H; Walker FR; Atalay M; Malm T; Grubman A; Tanila H; Kanninen KM
J Neuroinflammation; 2020 Sep; 17(1):271. PubMed ID: 32933545
[TBL] [Abstract][Full Text] [Related]
11. Tph2 Genetic Ablation Contributes to Senile Plaque Load and Astrogliosis in APP/PS1 Mice.
Xu CJ; Wang JL; Jing-Pan ; Min-Liao
Curr Alzheimer Res; 2019; 16(3):219-232. PubMed ID: 30827242
[TBL] [Abstract][Full Text] [Related]
12. Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologies.
Ji B; Maeda J; Sawada M; Ono M; Okauchi T; Inaji M; Zhang MR; Suzuki K; Ando K; Staufenbiel M; Trojanowski JQ; Lee VM; Higuchi M; Suhara T
J Neurosci; 2008 Nov; 28(47):12255-67. PubMed ID: 19020019
[TBL] [Abstract][Full Text] [Related]
13. 14,15-Epoxyeicosatrienoic Acid Alleviates Pathology in a Mouse Model of Alzheimer's Disease.
Chen W; Wang M; Zhu M; Xiong W; Qin X; Zhu X
J Neurosci; 2020 Oct; 40(42):8188-8203. PubMed ID: 32973044
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease.
Mori T; Koyama N; Arendash GW; Horikoshi-Sakuraba Y; Tan J; Town T
Glia; 2010 Feb; 58(3):300-14. PubMed ID: 19705461
[TBL] [Abstract][Full Text] [Related]
15. Retinal macroglia changes in a triple transgenic mouse model of Alzheimer's disease.
Edwards MM; Rodríguez JJ; Gutierrez-Lanza R; Yates J; Verkhratsky A; Lutty GA
Exp Eye Res; 2014 Oct; 127():252-60. PubMed ID: 25149907
[TBL] [Abstract][Full Text] [Related]
16. Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer's disease mouse model.
Katsouri L; Georgopoulos S
PLoS One; 2011; 6(7):e21880. PubMed ID: 21755005
[TBL] [Abstract][Full Text] [Related]
17. Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease.
Magga J; Puli L; Pihlaja R; Kanninen K; Neulamaa S; Malm T; Härtig W; Grosche J; Goldsteins G; Tanila H; Koistinaho J; Koistinaho M
J Neuroinflammation; 2010 Dec; 7():90. PubMed ID: 21138577
[TBL] [Abstract][Full Text] [Related]
18. Regulatory T cells decrease C3-positive reactive astrocytes in Alzheimer-like pathology.
Stym-Popper G; Matta K; Chaigneau T; Rupra R; Demetriou A; Fouquet S; Dansokho C; Toly-Ndour C; Dorothée G
J Neuroinflammation; 2023 Mar; 20(1):64. PubMed ID: 36890536
[TBL] [Abstract][Full Text] [Related]
19. Physiological expression of mutated TAU impaired astrocyte activity and exacerbates β-amyloid pathology in 5xFAD mice.
Farfara D; Sooliman M; Avrahami L; Royal TG; Amram S; Rozenstein-Tsalkovich L; Trudler D; Blanga-Kanfi S; Eldar-Finkelman H; Pahnke J; Rosenmann H; Frenkel D
J Neuroinflammation; 2023 Jul; 20(1):174. PubMed ID: 37496076
[TBL] [Abstract][Full Text] [Related]
20. The incretin analogue D-Ala2GIP reduces plaque load, astrogliosis and oxidative stress in an APP/PS1 mouse model of Alzheimer's disease.
Duffy AM; Hölscher C
Neuroscience; 2013 Jan; 228():294-300. PubMed ID: 23103794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
